# Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

> **NCT01704690** · PHASE2,PHASE3 · TERMINATED · sponsor: **Peking University** · enrollment: 4 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** S-1 and Paclitaxel
- **DRUG:** Paclitaxel and Cisplatin
- **DRUG:** 5-FU and Cisplatin

## Key facts

- **NCT ID:** NCT01704690
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** The enrollment of the study is much slower than expected.
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704690, "Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01704690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*